Imperative Care announced the launch of the Ikon 24 Pro guidewire. The next-generation neurovascular guidewire is designed ...

The key to successful inferior vena cava (IVC) and iliac vein recanalization is to understand the anatomy. One must take into account the overall anatomic situation, inflow and outflow, or more ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Physicians have recently reported stent fractures in self-expanding nitinol stents placed into the superficial femoral (SFA) and popliteal arteries. Presentations at national meetings, including the ...

Peripheral artery disease (PAD) of the lower extremities is a global pandemic of growing proportions. Between 2000 and 2010, the world’s population increased by 12.6%, and the prevalence of PAD has ...

Pelvic congestion syndrome (PCS) is a disease that is often undiagnosed in women with pelvic pain. Chronic pelvic pain affects approximately 15% of premenopausal women in the United States. The lack ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

The appeal of EVAR as a less invasive approach to abdominal aortic aneurysm exclusion is most pronounced in patients with significant medical comorbidities. Many of these patients have significant ...

Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.

Percutaneous transluminal peripheral angioplasty (PTA), with and without stenting, is an effective, accepted, and safe approach for treating iliac artery occlusive disease. Complications, although ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.